| UniProt ID | CASP2_HUMAN | |
|---|---|---|
| UniProt AC | P42575 | |
| Protein Name | Caspase-2 | |
| Gene Name | CASP2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 452 | |
| Subcellular Localization | ||
| Protein Description | Involved in the activation cascade of caspases responsible for apoptosis execution. Might function by either activating some proteins required for cell death or inactivating proteins necessary for cell survival.. | |
| Protein Sequence | MAAPSAGSWSTFQHKELMAADRGRRILGVCGMHPHHQETLKKNRVVLAKQLLLSELLEHLLEKDIITLEMRELIQAKVGSFSQNVELLNLLPKRGPQAFDAFCEALRETKQGHLEDMLLTTLSGLQHVLPPLSCDYDLSLPFPVCESCPLYKKLRLSTDTVEHSLDNKDGPVCLQVKPCTPEFYQTHFQLAYRLQSRPRGLALVLSNVHFTGEKELEFRSGGDVDHSTLVTLFKLLGYDVHVLCDQTAQEMQEKLQNFAQLPAHRVTDSCIVALLSHGVEGAIYGVDGKLLQLQEVFQLFDNANCPSLQNKPKMFFIQACRGDETDRGVDQQDGKNHAGSPGCEESDAGKEKLPKMRLPTRSDMICGYACLKGTAAMRNTKRGSWYIEALAQVFSERACDMHVADMLVKVNALIKDREGYAPGTEFHRCKEMSEYCSTLCRHLYLFPGHPPT | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MAAPSAGSW ------CCCCCCCCC | 28.25 | 19413330 | |
| 5 | Phosphorylation | ---MAAPSAGSWSTF ---CCCCCCCCCCHH | 40.30 | 28122231 | |
| 8 | Phosphorylation | MAAPSAGSWSTFQHK CCCCCCCCCCHHHHH | 19.98 | 25159151 | |
| 10 | Phosphorylation | APSAGSWSTFQHKEL CCCCCCCCHHHHHHH | 22.50 | 28122231 | |
| 15 | Ubiquitination | SWSTFQHKELMAADR CCCHHHHHHHHHHHH | 41.58 | - | |
| 22 | Methylation | KELMAADRGRRILGV HHHHHHHHCCHHHHH | 35.47 | - | |
| 41 | Ubiquitination | PHHQETLKKNRVVLA HHHHHHHHHCHHHHH | 56.26 | - | |
| 42 | Ubiquitination | HHQETLKKNRVVLAK HHHHHHHHCHHHHHH | 53.77 | - | |
| 46 (in isoform 2) | Ubiquitination | - | 3.77 | 21906983 | |
| 62 (in isoform 2) | Ubiquitination | - | 55.85 | 21906983 | |
| 67 | Phosphorylation | LLEKDIITLEMRELI HHHCCCCCHHHHHHH | 19.59 | 20068231 | |
| 77 | Sumoylation | MRELIQAKVGSFSQN HHHHHHHHHCCCHHC | 30.65 | - | |
| 77 | Ubiquitination | MRELIQAKVGSFSQN HHHHHHHHHCCCHHC | 30.65 | 21906983 | |
| 77 (in isoform 1) | Ubiquitination | - | 30.65 | 21906983 | |
| 77 | Sumoylation | MRELIQAKVGSFSQN HHHHHHHHHCCCHHC | 30.65 | - | |
| 93 (in isoform 1) | Ubiquitination | - | 70.70 | 21906983 | |
| 93 | Ubiquitination | ELLNLLPKRGPQAFD HHHHCCCCCCHHHHH | 70.70 | 21906983 | |
| 107 | Methylation | DAFCEALRETKQGHL HHHHHHHHHHHCCHH | 57.49 | - | |
| 139 | Phosphorylation | LSCDYDLSLPFPVCE CCCCCCCCCCCCCCC | 30.97 | 22817900 | |
| 151 | Phosphorylation | VCESCPLYKKLRLST CCCCCCCHHHHCCCC | 7.39 | - | |
| 153 | Ubiquitination | ESCPLYKKLRLSTDT CCCCCHHHHCCCCCC | 25.86 | - | |
| 157 | Phosphorylation | LYKKLRLSTDTVEHS CHHHHCCCCCCCCHH | 20.15 | 23401153 | |
| 158 | Phosphorylation | YKKLRLSTDTVEHSL HHHHCCCCCCCCHHC | 40.04 | 22617229 | |
| 160 | Phosphorylation | KLRLSTDTVEHSLDN HHCCCCCCCCHHCCC | 28.07 | 28102081 | |
| 164 | Phosphorylation | STDTVEHSLDNKDGP CCCCCCHHCCCCCCC | 24.74 | 28450419 | |
| 168 | Ubiquitination | VEHSLDNKDGPVCLQ CCHHCCCCCCCEEEE | 64.82 | - | |
| 177 | Ubiquitination | GPVCLQVKPCTPEFY CCEEEEEECCCHHHH | 22.78 | - | |
| 214 | Ubiquitination | NVHFTGEKELEFRSG CCEECCCEEEEECCC | 69.78 | - | |
| 254 | Ubiquitination | TAQEMQEKLQNFAQL HHHHHHHHHHHHHHC | 38.18 | - | |
| 284 | Phosphorylation | HGVEGAIYGVDGKLL CCCCCEEECCCCCCH | 15.57 | 29496907 | |
| 311 | Ubiquitination | NCPSLQNKPKMFFIQ CCHHHCCCCCEEEEE | 32.81 | - | |
| 335 | Ubiquitination | GVDQQDGKNHAGSPG CCCCCCCCCCCCCCC | 54.58 | - | |
| 340 | Phosphorylation | DGKNHAGSPGCEESD CCCCCCCCCCCCCCH | 20.92 | 23401153 | |
| 346 | Phosphorylation | GSPGCEESDAGKEKL CCCCCCCCHHCCCCC | 15.51 | 29396449 | |
| 350 | Ubiquitination | CEESDAGKEKLPKMR CCCCHHCCCCCCCCC | 54.09 | - | |
| 352 | Ubiquitination | ESDAGKEKLPKMRLP CCHHCCCCCCCCCCC | 73.84 | - | |
| 368 | Phosphorylation | RSDMICGYACLKGTA CCCCCHHHHHHHCCH | 6.96 | - | |
| 374 | Phosphorylation | GYACLKGTAAMRNTK HHHHHHCCHHHCCCC | 15.06 | - | |
| 384 | Phosphorylation | MRNTKRGSWYIEALA HCCCCCCCHHHHHHH | 22.27 | 24144214 | |
| 395 | Phosphorylation | EALAQVFSERACDMH HHHHHHHHHHCCHHH | 27.58 | 24144214 | |
| 409 | Ubiquitination | HVADMLVKVNALIKD HHHHHHHHHHHHHCC | 26.30 | - | |
| 415 | Ubiquitination | VKVNALIKDREGYAP HHHHHHHCCCCCCCC | 52.13 | 2190698 | |
| 415 (in isoform 1) | Ubiquitination | - | 52.13 | 21906983 | |
| 420 | Phosphorylation | LIKDREGYAPGTEFH HHCCCCCCCCCCCCH | 12.60 | - | |
| 430 | Ubiquitination | GTEFHRCKEMSEYCS CCCCHHHHHHHHHHH | 57.31 | - |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CASP2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CASP2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| CRADD_HUMAN | CRADD | physical | 15073321 | |
| PIDD1_HUMAN | PIDD1 | physical | 15073321 | |
| CRADD_HUMAN | CRADD | physical | 11156409 | |
| BID_HUMAN | BID | physical | 11399776 | |
| CASP2_HUMAN | CASP2 | physical | 11832478 | |
| BID_HUMAN | BID | physical | 11832478 | |
| BCL2_HUMAN | BCL2 | genetic | 11832478 | |
| B2CL1_HUMAN | BCL2L1 | genetic | 11832478 | |
| CASP9_HUMAN | CASP9 | genetic | 11832478 | |
| XIAP_HUMAN | XIAP | genetic | 11832478 | |
| NOL3_HUMAN | NOL3 | physical | 9560245 | |
| CCND3_HUMAN | CCND3 | physical | 12011445 | |
| MDM2_HUMAN | MDM2 | physical | 21726810 | |
| RAI1_HUMAN | RAI1 | physical | 21900206 | |
| EF1A1_HUMAN | EEF1A1 | physical | 21900206 | |
| RXRA_HUMAN | RXRA | physical | 21900206 | |
| RL30_HUMAN | RPL30 | physical | 21988832 | |
| CRADD_HUMAN | CRADD | physical | 23049853 | |
| CRYAB_HUMAN | CRYAB | physical | 23049853 | |
| CASP2_HUMAN | CASP2 | physical | 25416956 | |
| CRADD_HUMAN | CRADD | physical | 25416956 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |